SSE: 2607 - Shanghai Pharmaceuticals Holding Co., Ltd

Yield per half year: 0%
Dividend yield: +4.98%
Sector: Healthcare

Reporting Shanghai Pharmaceuticals Holding Co., Ltd

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
70.32
Выручка, млрд ¥
241.31
Чистая прибыль, млрд ¥
5.88
EV, млрд ¥
77.18
EBITDA, млрд ¥
9.96


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
38.11
Долг, млрд ¥
50.66


Share

IFRS
Reporting Annual
LTM 5 year average CAGR 5
EPS 1.72


Efficiency

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 9.61 7.85
ROA, % 2.78 4.30
ROS, % 2.44 2.44 2.44 2.44 8.11
ROCE, % 0 0 0.00
Ebit margin, % 0 0
Рентаб EBITDA, % 4.13 4.13 -351.29
Чистая рентаб, % 2.44 8.10
Operation Margin, % 0 0 0 0 4.29


Coefficients

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
7.76 36.76
P/BV
0.66 3.67
P/S
0.19 13.01
P/FCF
0 0 0 0 7.85
E/P
0.0836 0.0836 0.0836 0.0836 0.03
EV/EBITDA
6.96 19.30
EV/EBIT
0 0 0
EV/S
0.3198 0.3198 0.3198 0.3198 59.91
EV/FCF
0 0 0 4.07
Debt/EBITDA
5.09 5.09 5.09 5.09 1.91
Netdebt/Ebitda
0 0 0 0 0.24
Debt/Ratio
0 0 0 0 0.07
Debt/Equity
0 0 0 0 0.14
Debt/Net Income
8.62 8.62 8.62 8.62 3.99
Бета
0 0 0 0 0.16
Индекс Альтмана
0 0 0 0 7.02


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0.66
Див доход, ао, %
4.98 0.81
Дивиденды / прибыль, %
26.81 41.32


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
47877 47877